Masatoshi Jinnin

10.0k total citations · 1 hit paper
234 papers, 7.0k citations indexed

About

Masatoshi Jinnin is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Dermatology. According to data from OpenAlex, Masatoshi Jinnin has authored 234 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Pathology and Forensic Medicine, 65 papers in Molecular Biology and 64 papers in Dermatology. Recurrent topics in Masatoshi Jinnin's work include Systemic Sclerosis and Related Diseases (75 papers), Dermatologic Treatments and Research (33 papers) and Inflammatory Myopathies and Dermatomyositis (23 papers). Masatoshi Jinnin is often cited by papers focused on Systemic Sclerosis and Related Diseases (75 papers), Dermatologic Treatments and Research (33 papers) and Inflammatory Myopathies and Dermatomyositis (23 papers). Masatoshi Jinnin collaborates with scholars based in Japan, United States and India. Masatoshi Jinnin's co-authors include Hironobu Ihn, Kunihiko Tamaki, Satoshi Fukushima, Yoshihide Asano, Kenichi Yamane, Takamitsu Makino, Yoshihiro Mimura, Ikko Kajihara, Shinichi Masuguchi and Katsunari Makino and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Masatoshi Jinnin

221 papers receiving 7.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

ISSVA Classification of Vascular Anomalies and Molecular Biology

2022 118 citations Kayo Kunimoto, Yuki Yamamoto et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Masatoshi Jinnin Japan	47	2.7k	1.9k	1.4k	1.3k	1.3k	234	7.0k
Maria Trojanowska United States	61	4.6k 1.7×	4.0k 2.1×	952 0.7×	661 0.5×	1.7k 1.3×	171	10.0k
Hironobu Ihn Japan	58	4.5k 1.7×	4.1k 2.1×	1.9k 1.4×	1.6k 1.2×	2.2k 1.7×	384	11.8k
Franck Verrecchia France	40	3.4k 1.2×	749 0.4×	1.0k 0.8×	816 0.6×	718 0.5×	99	6.2k
Clara Dees Germany	43	2.5k 0.9×	2.2k 1.1×	541 0.4×	297 0.2×	1.2k 0.9×	85	5.8k
Astrid Jüngel Switzerland	37	2.1k 0.8×	1.1k 0.6×	601 0.4×	826 0.6×	1.1k 0.9×	67	4.6k
Francisco Vega United States	44	1.6k 0.6×	2.6k 1.3×	2.2k 1.6×	415 0.3×	1.1k 0.8×	266	6.2k
Hitoshi Okochi Japan	36	3.1k 1.1×	722 0.4×	612 0.4×	453 0.3×	942 0.7×	108	6.3k
Marco Santucci Italy	41	920 0.3×	2.1k 1.1×	1.9k 1.4×	525 0.4×	728 0.6×	159	5.5k
George Bou–Gharios United Kingdom	44	3.4k 1.2×	842 0.4×	565 0.4×	465 0.3×	578 0.4×	158	6.6k
Gaetano Magro Italy	39	1.5k 0.5×	792 0.4×	678 0.5×	506 0.4×	506 0.4×	300	5.7k

Countries citing papers authored by Masatoshi Jinnin

Since Specialization

Citations

This map shows the geographic impact of Masatoshi Jinnin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Jinnin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Jinnin more than expected).

Fields of papers citing papers by Masatoshi Jinnin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masatoshi Jinnin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Jinnin. The network helps show where Masatoshi Jinnin may publish in the future.

Co-authorship network of co-authors of Masatoshi Jinnin

This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Jinnin. A scholar is included among the top collaborators of Masatoshi Jinnin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Jinnin. Masatoshi Jinnin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jinnin, Masatoshi, Toshio Shimokawa, Akiko Kishi, et al.. (2025). Topical sirolimus therapy for cutaneous vascular anomalies: A randomized phase II clinical trial. The Journal of Dermatology. 52(5). 872–887. 1 indexed citations

Fujimoto, Manabu, Yoshihide Asano, Hirahito Endo, et al.. (2024). Predictors of clinical features in early‐onset severe systemic sclerosis: An analysis from a multicenter prospective observational Japanese cohort. The Journal of Dermatology. 51(10). 1290–1297.

Sakata, Mariko, Kayo Kunimoto, Yutaka Inaba, et al.. (2023). Analysis of cytokine profiles in sera of single and multiple infantile hemangioma. The Journal of Dermatology. 50(7). 906–911. 2 indexed citations

Matsuda, Mitsuhiro, Hiroshi Koga, Chika Ohata, et al.. (2022). Anti‐desmoglein 1 antibody‐positive mother and antibody‐negative child with Darier's disease. The Journal of Dermatology. 50(2). 250–253.

Inaba, Yutaka, Nobuo Kanazawa, Kayo Kunimoto, et al.. (2022). Dupilumab Improves Pruritus in Netherton Syndrome: A Case Study. Children. 9(3). 310–310. 14 indexed citations

Inaba, Hidefumi, Gen Inoue, Takakazu Sugita, et al.. (2022). Human Leukocyte Antigens and Biomarkers in Type 1 Diabetes Mellitus Induced by Immune-Checkpoint Inhibitors. Endocrinology and Metabolism. 37(1). 84–95. 23 indexed citations

Inaba, Hidefumi, Hiroyuki Ariyasu, Hiroshi Iwakura, et al.. (2020). Predictive and sensitive biomarkers for thyroid dysfunctions during treatment with immune‐checkpoint inhibitors. Cancer Science. 111(5). 1468–1477. 109 indexed citations

Ikeda, Takaharu, Chie Miyabe, Masatoshi Jinnin, & Tamihiro Kawakami. (2020). Peristomal pyoderma gangrenosum in patients who underwent colectomy and colostomy for incurable inflammatory bowel disease. SHILAP Revista de lepidopterología. 3(1). 17–18. 1 indexed citations

Yamamoto, Toshiyuki, Yoshihide Asano, Shinichi Sato, et al.. (2020). Characteristics of Japanese patients with eosinophilic fasciitis: A brief multicenter study. The Journal of Dermatology. 47(12). 1391–1394. 7 indexed citations

10.

Takamatsu, Koutaro, Shunya Nakane, Shigeaki Suzuki, et al.. (2018). Immune checkpoint inhibitors in the onset of myasthenia gravis with hyperCKemia. Annals of Clinical and Translational Neurology. 5(11). 1421–1427. 29 indexed citations

11.

Miyashita, Azusa, Satoshi Fukushima, Satoshi Nakahara, et al.. (2016). Immunotherapy against Metastatic Melanoma with Human iPS Cell–Derived Myeloid Cell Lines Producing Type I Interferons. Cancer Immunology Research. 4(3). 248–258. 24 indexed citations

12.

Jinnin, Masatoshi, Mikio Masuzawa, Zhongzhi Wang, et al.. (2015). NUP160–SLC43A3 Is a Novel Recurrent Fusion Oncogene in Angiosarcoma. Cancer Research. 75(21). 4458–4465. 41 indexed citations

13.

Aoi, Jun, Motoyoshi Endo, Tsuyoshi Kadomatsu, et al.. (2013). Angiopoietin-like Protein 2 Accelerates Carcinogenesis by Activating Chronic Inflammation and Oxidative Stress. Molecular Cancer Research. 12(2). 239–249. 52 indexed citations

14.

Nakashima, Taiji, Masatoshi Jinnin, Keitaro Yamane, et al.. (2012). Impaired IL-17 Signaling Pathway Contributes to the Increased Collagen Expression in Scleroderma Fibroblasts. The Journal of Immunology. 188(8). 3573–3583. 167 indexed citations

15.

Honda, Noritoshi, Masatoshi Jinnin, Katsunari Makino, et al.. (2012). miR-150 Down-Regulation Contributes to the Constitutive Type I Collagen Overexpression in Scleroderma Dermal Fibroblasts via the Induction of Integrin β3. American Journal Of Pathology. 182(1). 206–216. 107 indexed citations

16.

Masuguchi, Shinichi, Masatoshi Jinnin, Satoshi Fukushima, et al.. (2011). The expression of HER-2 in extramammary Paget's disease. BioScience Trends. 5(4). 151–155. 24 indexed citations

17.

Aoi, Jun, Motoyoshi Endo, Tsuyoshi Kadomatsu, et al.. (2011). Angiopoietin-like Protein 2 Is an Important Facilitator of Inflammatory Carcinogenesis and Metastasis. Cancer Research. 71(24). 7502–7512. 113 indexed citations

18.

Ihn, Hironobu, Keisaku Yamane, Yoshihide Asano, Masatoshi Jinnin, & K. Tamaki. (2005). Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts. Lara D. Veeken. 45(2). 157–165. 42 indexed citations

19.

Mimura, Yoshihiro, Hironobu Ihn, Masatoshi Jinnin, et al.. (2004). Epidermal Growth Factor Induces Fibronectin Expression in Human Dermal Fibroblasts via Protein Kinase C δ Signaling Pathway. Journal of Investigative Dermatology. 122(6). 1390–1398. 36 indexed citations

20.

Ihn, Hironobu, Kenichi Yamane, Yoshihide Asano, Masatoshi Jinnin, & Kunihiko Tamaki. (2004). Constitutive phosphorylated Smad3 interacts with Sp1 and p300/CBP in scleroderma fibroblasts. 36(2). 107. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact